Expression of Type III Hyperlipoproteinemia in Apolipoprotein E2 (Arg158→Cys) Homozygotes Is Associated With Hyperinsulinemia
- 1 February 2002
- journal article
- other
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 22 (2) , 294-299
- https://doi.org/10.1161/hq0202.102919
Abstract
Type III hyperlipoproteinemia (HLP) is mainly found in homozygous carriers of apolipoprotein E2 (apoE2, Arg158→Cys). Only a small percentage (<5%) of these apoE2 homozygotes develops hyperlipidemia...Keywords
This publication has 29 references indexed in Scilit:
- Insulin Sensitivity Measured With the Minimal Model is Higher in Moderately Overweight Women With Predominantly Lower Body FatHormone and Metabolic Research, 1999
- Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesityInternational Journal of Obesity, 1998
- Prevalence and Determinants of Glucose Intolerance in a Dutch Caucasian Population: The Hoorn StudyDiabetes Care, 1995
- Expression of type III hyperlipoproteinaemia in a subject with secondary hypothyroidism bearing the apolipoprotein E2/2 phenotypeJournal of Internal Medicine, 1991
- Apolipoprotein ECurrent Opinion in Lipidology, 1990
- Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell BiologyScience, 1988
- Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptors.Journal of Clinical Investigation, 1981
- Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modificationBiochemistry, 1981
- Polymorphism of apolipoprotein EClinical Genetics, 1979
- Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in manNature, 1977